Is RenovoRx Inc (RNXT) Stock About to Get Hot Friday?

Overall market sentiment has been neutral on RenovoRx Inc (RNXT) stock lately. RNXT receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator.

RenovoRx Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on RNXT!

See Full RNXT Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With RNXT Stock Today?

RenovoRx Inc (RNXT) stock is up 3.91% while the S&P 500 has fallen -0.2% as of 10:37 AM on Friday, Oct 6. RNXT has risen $0.05 from the previous closing price of $1.15 on volume of 4,983 shares. Over the past year the S&P 500 has risen 12.33% while RNXT has fallen -43.13%. RNXT lost -$1.05 per share in the over the last 12 months.

More About RenovoRx Inc

RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem. Click Here to get the full Stock Report for RenovoRx Inc stock.